↓ Skip to main content

The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report

Overview of attention for article published in BMC Cancer, January 2006
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
1 tweeter
patent
2 patents

Citations

dimensions_citation
108 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report
Published in
BMC Cancer, January 2006
DOI 10.1186/1471-2407-6-7
Pubmed ID
Authors

Jürgen C Becker, Roland Houben, Claudia S Vetter, Eva B Bröcker

Abstract

Since tacrolimus ointment was approved by the U.S. Food and Drug Administration (FDA) as a promising treatment for atopic dermatitis, it has been approved in more than 30 additional countries, including numerous European Union member nations. Moreover, in the current clinical routine the use of this drug is no longer restricted to the approved indication, but has been extended to a wide variety of inflammatory skin diseases including some with the potential of malignant transformation. So far, the side-effects reported from the topical use of tacrolimus have been relatively minor (e.g. burning, pruritus, erythema). Recently, however, the FDA reviewed the safety of topical tacrolimus, which resulted in a warning that the use of calcineurin inhibitors may be associated with an increased risk of cancer.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 24%
Researcher 8 15%
Student > Ph. D. Student 7 13%
Student > Bachelor 3 6%
Professor 3 6%
Other 8 15%
Unknown 12 22%
Readers by discipline Count As %
Medicine and Dentistry 26 48%
Agricultural and Biological Sciences 3 6%
Nursing and Health Professions 3 6%
Social Sciences 2 4%
Mathematics 1 2%
Other 5 9%
Unknown 14 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2016.
All research outputs
#3,344,434
of 12,372,945 outputs
Outputs from BMC Cancer
#855
of 4,558 outputs
Outputs of similar age
#37,439
of 141,802 outputs
Outputs of similar age from BMC Cancer
#7
of 18 outputs
Altmetric has tracked 12,372,945 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 4,558 research outputs from this source. They receive a mean Attention Score of 3.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 141,802 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.